Nothing Special   »   [go: up one dir, main page]

AU2001233017A1 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides

Info

Publication number
AU2001233017A1
AU2001233017A1 AU2001233017A AU3301701A AU2001233017A1 AU 2001233017 A1 AU2001233017 A1 AU 2001233017A1 AU 2001233017 A AU2001233017 A AU 2001233017A AU 3301701 A AU3301701 A AU 3301701A AU 2001233017 A1 AU2001233017 A1 AU 2001233017A1
Authority
AU
Australia
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233017A
Inventor
Rodje T. Drmanac
Chenghua Liu
Y. Tom Tang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyseq Inc
Original Assignee
Hyseq Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc filed Critical Hyseq Inc
Publication of AU2001233017A1 publication Critical patent/AU2001233017A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001233017A 2000-01-25 2001-01-25 Novel nucleic acids and polypeptides Abandoned AU2001233017A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49140400A 2000-01-25 2000-01-25
US09491404 2000-01-25
PCT/US2001/002623 WO2001055437A2 (en) 2000-01-25 2001-01-25 Novel nucleic acids and polypeptides

Publications (1)

Publication Number Publication Date
AU2001233017A1 true AU2001233017A1 (en) 2001-08-07

Family

ID=23952072

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233017A Abandoned AU2001233017A1 (en) 2000-01-25 2001-01-25 Novel nucleic acids and polypeptides

Country Status (4)

Country Link
US (2) US6635742B1 (en)
AU (1) AU2001233017A1 (en)
CA (1) CA2398554A1 (en)
WO (1) WO2001055437A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5956487A (en) * 1996-10-25 1999-09-21 Hewlett-Packard Company Embedding web access mechanism in an appliance for user interface functions including a web server and web browser
US7241862B2 (en) * 1998-05-15 2007-07-10 Genentech, Inc. Polypeptides that induce cell proliferation or induce fetal hemoglobin
DK1109937T3 (en) * 1998-09-02 2009-03-09 Diadexus Inc Procedures for diagnosis, monitoring, staging and imaging for various cancers
NZ536320A (en) 1999-03-23 2006-04-28 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1953173B1 (en) * 1999-06-15 2009-11-18 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids endoding the same
US20050208498A1 (en) * 2000-01-25 2005-09-22 Nuvelo, Inc. Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein
US20020142953A1 (en) * 2000-04-14 2002-10-03 Ballinger Dennis G. Materials and methods relating to lipid metabolism
WO2001081414A2 (en) * 2000-04-27 2001-11-01 Millennium Pharmaceuticals, Inc. Integrin alpha subunit and uses thereof
EP1354947A4 (en) 2000-11-22 2005-01-19 Yamanouchi Pharma Co Ltd Novel polypeptide
US20030211039A1 (en) * 2001-05-29 2003-11-13 Macina Roberto A. Method of diagnosing, monitoring, staging, imaging and treating colon cancer
WO2002099044A2 (en) * 2001-06-05 2002-12-12 Exelixis, Inc. B3galts as modifiers of the p53 pathway and methods of use
WO2003044197A1 (en) * 2001-11-21 2003-05-30 Japan Science And Technology Agency Huntington’s disease gene transcriptional factors
EP1371660A1 (en) * 2002-06-14 2003-12-17 Consejo Superior De Investigaciones Cientificas Vaccine
EP1557466B1 (en) * 2002-09-27 2009-09-02 Dainippon Sumitomo Pharma Co., Ltd. Tumor antigen protein and utilization thereof
EP1442749A1 (en) * 2003-01-31 2004-08-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of anti-CD100 antibodies for the treatment and the diagnosis of inflammatory disorder affecting the central nervous system
KR20050106459A (en) * 2003-02-28 2005-11-09 미쯔비시 웰 파마 가부시키가이샤 Monoclonal antibody, gene encoding the same, hybridoma, medicinal composition and diagnostic reagent
JP2007512836A (en) * 2003-12-02 2007-05-24 ヌベロ， インコーポレイテッド Methods of treatment and diagnosis using targeting of cells expressing killer cell immunoglobulin-like receptor-like proteins
WO2006090389A2 (en) 2005-02-24 2006-08-31 Compugen Ltd. Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
WO2007087131A2 (en) * 2006-01-05 2007-08-02 The Johns Hopkins University Peptide prodrugs
EP2058404A1 (en) * 2007-11-12 2009-05-13 Deutsches Institut für Ernährungsforschung Zfp69, Znf642 and Znf643 as markers for obesity-associated diabetes
CN102257138B (en) 2008-10-20 2013-06-19 大日本住友制药株式会社 Tumor antigen peptide and use thereof
DK2427212T3 (en) 2009-05-08 2017-12-04 Vaccinex Inc ANTI-CD100 ANTIBODIES AND PROCEDURES FOR USE THEREOF
CN104168956A (en) 2011-10-11 2014-11-26 瓦西尼斯公司 Use of semaphorin-4D binding molecules for modulation of blood brain barrier permeability
US9090709B2 (en) 2012-03-28 2015-07-28 Vaccinex, Inc. Anti-SEMA4D antibodies and epitopes
US10494440B2 (en) * 2012-05-11 2019-12-03 Vaccinex, Inc. Use of semaphorin-4D binding molecules to promote neurogenesis following stroke
MX2015017485A (en) 2013-06-25 2016-03-31 Vaccinex Inc Use of semaphorin-4d inhibitory molecules in combination with an immune modulating therapy to inhibit tumor growth and metastases.
NZ630881A (en) 2013-10-10 2016-03-31 Vaccinex Inc Use of semaphorin-4d binding molecules for treatment of atherosclerosis
NZ630892A (en) 2013-10-21 2016-03-31 Vaccinex Inc Use of semaphorin-4d binding molecules for treating neurodegenerative disorders
TW202016131A (en) * 2018-05-16 2020-05-01 德商英麥提克生物技術股份有限公司 Peptides for use in immunotherapy against cancers
CN113321705B (en) * 2021-06-15 2022-04-26 北京林业大学 Elastase inhibitory peptide and preparation method and application thereof
CN117024573B (en) * 2023-08-10 2024-08-20 华中农业大学 Collagen peptide with iron chelating activity and preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2128227C1 (en) 1989-12-22 1999-03-27 Апплайд Резеч Системз АРС Холдинг Н.В. (NL) (Антильские острова) Method of an activation of transcriptionally silent gene
WO1992020808A1 (en) 1991-05-15 1992-11-26 Cell Genesys, Inc. Genomic modifications with homologous dna targeting
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
EP0960937B1 (en) 1996-09-11 2007-11-14 Dainippon Sumitomo Pharma Co., Ltd. Novel semaphorin gene: semaphorin y
AU2000299A (en) 1997-12-19 1999-07-12 Zymogenetics Inc. Semaphorin zsmf-3

Also Published As

Publication number Publication date
US20040220383A1 (en) 2004-11-04
US6635742B1 (en) 2003-10-21
US6818754B1 (en) 2004-11-16
CA2398554A1 (en) 2001-08-02
WO2001055437A2 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001234944A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001296235A1 (en) Novel nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
AU2002246502A1 (en) Nucleic acids and polypeptides
AU2002366951A1 (en) Novel nucleic acids and polypeptides
AU2002326877A1 (en) Novel nucleic acids and polypeptides
AU2002314709A1 (en) Novel nucleic acids and polypeptides
AU2002343417A1 (en) Novel nucleic acids and polypeptides
AU2001241511A1 (en) Novel nucleic acids and polypeptides
AU2001292561A1 (en) Nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
WO2002016439A8 (en) Novel nucleic acids and polypeptides
EP1341803A4 (en) Novel nucleic acids and polypeptides
AU3511100A (en) Novel nucleic acids and polypeptides
AU2002250419A1 (en) Novel nucleic acids and polypeptides
AU2001263005A1 (en) Novel nucleic acids and polypeptides
AU2001252926A1 (en) Novel nucleic acids and polypeptides
EP1268762A4 (en) Novel nucleic acids and polypeptides